title: [A reply to Ake Sjoholm et al about new agents against type 2 diabetes: safety data prior to wide utilization or the other way round?].
authors.affiliation: Verksamhetsområde internmedicin, Södersjukhuset AB.
authors.forename: Eva Andersén
authors.initials: EA
authors.lastname: Karlsson
authors.forename: Mats
authors.initials: M
authors.lastname: Palmér
authors.forename: Rickard
authors.initials: R
authors.lastname: Malmström
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D019317:Evidence-Based Medicine; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D012449:Safety
chemical_list: D007004:Hypoglycemic Agents